Cargando…
Proteomic characterisations of ulcerative colitis endoscopic biopsies associate with clinically relevant histological measurements of disease severity
AIMS AND METHODS: Accurate protein measurements using formalin-fixed biopsies are needed to improve disease characterisation. This feasibility study used targeted and global mass spectrometry (MS) to interrogate a spectrum of disease severities using 19 ulcerative colitis (UC) biopsies. RESULTS: Tar...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411881/ https://www.ncbi.nlm.nih.gov/pubmed/34353876 http://dx.doi.org/10.1136/jclinpath-2021-207718 |
_version_ | 1784775364681138176 |
---|---|
author | Gruver, Aaron M Westfall, Matt D Ackermann, Bradley L Hill, Salisha Morrison, Ryan D Bodo, Juraj Lai, Keith K Gemperline, David C Hsi, Eric D Liebler, Daniel C Schmitz, Jochen Benschop, Robert J |
author_facet | Gruver, Aaron M Westfall, Matt D Ackermann, Bradley L Hill, Salisha Morrison, Ryan D Bodo, Juraj Lai, Keith K Gemperline, David C Hsi, Eric D Liebler, Daniel C Schmitz, Jochen Benschop, Robert J |
author_sort | Gruver, Aaron M |
collection | PubMed |
description | AIMS AND METHODS: Accurate protein measurements using formalin-fixed biopsies are needed to improve disease characterisation. This feasibility study used targeted and global mass spectrometry (MS) to interrogate a spectrum of disease severities using 19 ulcerative colitis (UC) biopsies. RESULTS: Targeted assays for CD8, CD19, CD132 (interleukin-2 receptor subunit gamma/common cytokine receptor gamma chain), FOXP3 (forkhead box P3) and IL17RA (interleukin 17 receptor A) were successful; however, assays for IL17A (interleukin 17A), IL23 (p19) (interleukin 23, alpha subunit p19) and IL23R (interleukin 23 receptor) did not permit target detection. Global proteome analysis (4200 total proteins) was performed to identify pathways associated with UC progression. Positive correlation was observed between histological scores indicating active colitis and neutrophil-related measurements (R(2)=0.42–0.72); inverse relationships were detected with cell junction targets (R(2)=0.49–0.71) and β-catenin (R(2)=0.51–0.55) attributed to crypt disruption. An exploratory accuracy assessment with Geboes Score and Robarts Histopathology Index cut-offs produced sensitivities/specificities of 72.7%/75.0% and 100.0%/81.8%, respectively. CONCLUSIONS: Pathologist-guided MS assessments provide a complementary approach to histological scoring systems. Additional studies are indicated to verify the utility of this novel approach. |
format | Online Article Text |
id | pubmed-9411881 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-94118812022-09-12 Proteomic characterisations of ulcerative colitis endoscopic biopsies associate with clinically relevant histological measurements of disease severity Gruver, Aaron M Westfall, Matt D Ackermann, Bradley L Hill, Salisha Morrison, Ryan D Bodo, Juraj Lai, Keith K Gemperline, David C Hsi, Eric D Liebler, Daniel C Schmitz, Jochen Benschop, Robert J J Clin Pathol Short Report AIMS AND METHODS: Accurate protein measurements using formalin-fixed biopsies are needed to improve disease characterisation. This feasibility study used targeted and global mass spectrometry (MS) to interrogate a spectrum of disease severities using 19 ulcerative colitis (UC) biopsies. RESULTS: Targeted assays for CD8, CD19, CD132 (interleukin-2 receptor subunit gamma/common cytokine receptor gamma chain), FOXP3 (forkhead box P3) and IL17RA (interleukin 17 receptor A) were successful; however, assays for IL17A (interleukin 17A), IL23 (p19) (interleukin 23, alpha subunit p19) and IL23R (interleukin 23 receptor) did not permit target detection. Global proteome analysis (4200 total proteins) was performed to identify pathways associated with UC progression. Positive correlation was observed between histological scores indicating active colitis and neutrophil-related measurements (R(2)=0.42–0.72); inverse relationships were detected with cell junction targets (R(2)=0.49–0.71) and β-catenin (R(2)=0.51–0.55) attributed to crypt disruption. An exploratory accuracy assessment with Geboes Score and Robarts Histopathology Index cut-offs produced sensitivities/specificities of 72.7%/75.0% and 100.0%/81.8%, respectively. CONCLUSIONS: Pathologist-guided MS assessments provide a complementary approach to histological scoring systems. Additional studies are indicated to verify the utility of this novel approach. BMJ Publishing Group 2022-09 2021-08-05 /pmc/articles/PMC9411881/ /pubmed/34353876 http://dx.doi.org/10.1136/jclinpath-2021-207718 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Short Report Gruver, Aaron M Westfall, Matt D Ackermann, Bradley L Hill, Salisha Morrison, Ryan D Bodo, Juraj Lai, Keith K Gemperline, David C Hsi, Eric D Liebler, Daniel C Schmitz, Jochen Benschop, Robert J Proteomic characterisations of ulcerative colitis endoscopic biopsies associate with clinically relevant histological measurements of disease severity |
title | Proteomic characterisations of ulcerative colitis endoscopic biopsies associate with clinically relevant histological measurements of disease severity |
title_full | Proteomic characterisations of ulcerative colitis endoscopic biopsies associate with clinically relevant histological measurements of disease severity |
title_fullStr | Proteomic characterisations of ulcerative colitis endoscopic biopsies associate with clinically relevant histological measurements of disease severity |
title_full_unstemmed | Proteomic characterisations of ulcerative colitis endoscopic biopsies associate with clinically relevant histological measurements of disease severity |
title_short | Proteomic characterisations of ulcerative colitis endoscopic biopsies associate with clinically relevant histological measurements of disease severity |
title_sort | proteomic characterisations of ulcerative colitis endoscopic biopsies associate with clinically relevant histological measurements of disease severity |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411881/ https://www.ncbi.nlm.nih.gov/pubmed/34353876 http://dx.doi.org/10.1136/jclinpath-2021-207718 |
work_keys_str_mv | AT gruveraaronm proteomiccharacterisationsofulcerativecolitisendoscopicbiopsiesassociatewithclinicallyrelevanthistologicalmeasurementsofdiseaseseverity AT westfallmattd proteomiccharacterisationsofulcerativecolitisendoscopicbiopsiesassociatewithclinicallyrelevanthistologicalmeasurementsofdiseaseseverity AT ackermannbradleyl proteomiccharacterisationsofulcerativecolitisendoscopicbiopsiesassociatewithclinicallyrelevanthistologicalmeasurementsofdiseaseseverity AT hillsalisha proteomiccharacterisationsofulcerativecolitisendoscopicbiopsiesassociatewithclinicallyrelevanthistologicalmeasurementsofdiseaseseverity AT morrisonryand proteomiccharacterisationsofulcerativecolitisendoscopicbiopsiesassociatewithclinicallyrelevanthistologicalmeasurementsofdiseaseseverity AT bodojuraj proteomiccharacterisationsofulcerativecolitisendoscopicbiopsiesassociatewithclinicallyrelevanthistologicalmeasurementsofdiseaseseverity AT laikeithk proteomiccharacterisationsofulcerativecolitisendoscopicbiopsiesassociatewithclinicallyrelevanthistologicalmeasurementsofdiseaseseverity AT gemperlinedavidc proteomiccharacterisationsofulcerativecolitisendoscopicbiopsiesassociatewithclinicallyrelevanthistologicalmeasurementsofdiseaseseverity AT hsiericd proteomiccharacterisationsofulcerativecolitisendoscopicbiopsiesassociatewithclinicallyrelevanthistologicalmeasurementsofdiseaseseverity AT lieblerdanielc proteomiccharacterisationsofulcerativecolitisendoscopicbiopsiesassociatewithclinicallyrelevanthistologicalmeasurementsofdiseaseseverity AT schmitzjochen proteomiccharacterisationsofulcerativecolitisendoscopicbiopsiesassociatewithclinicallyrelevanthistologicalmeasurementsofdiseaseseverity AT benschoprobertj proteomiccharacterisationsofulcerativecolitisendoscopicbiopsiesassociatewithclinicallyrelevanthistologicalmeasurementsofdiseaseseverity |